1. Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients with Peritoneal Dissemination

   • Yoshiyuki Fujiwara

   Gastrointestinal Oncology 23 August 2011 Pages: 187 - 188

2. Re: Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients with Peritoneal Dissemination

   • Jung Ho Shim
   • Cho Hyun Park
   • Kyo Young Song

   Gastrointestinal Oncology 23 August 2011 Pages: 189 - 189

3. HER2-Positive Gastric Cancer

   • Haralabos Demetriades

   Gastrointestinal Oncology 16 August 2011 Pages: 190 - 191

4. Preventive and Therapeutic Implications of Positive CDH1 Testing in Diffuse Gastric Cancer

   • Christof Hottenrott

   Gastrointestinal Oncology 15 July 2011 Pages: 192 - 193

5. Re: Aggressive Surgical Approach for Patients with T4 Gastric Carcinoma: Promise or Myth?

   • Jung Ho Shim
   • Seong Il O
   • Kyo Young Song

   Gastrointestinal Oncology 02 July 2011 Pages: 194 - 194

6. Letter to the Editor Reply to “Re: Aggressive Surgical Approach for Patients with T4 Gastric Carcinoma: Promise or Myth?”

   • Ta-Sen Yeh

   Gastrointestinal Oncology 02 July 2011 Pages: 195 - 195

7. Oral Vitamin B12 Therapy

   • Emmanuel Andrès
   • Mustapha Mecili

   Gastrointestinal Oncology 28 June 2011 Pages: 196 - 198

8. Oral Vitamin B12 Therapy after Total Gastrectomy

   • Hyoung-Il Kim
   • Woo Jin Hyung

   Gastrointestinal Oncology 30 June 2011 Pages: 199 - 199

9. Slow Progress in Predicting and Preventing Fatal Gastric Cancer Peritoneal Recurrence

   • John Spiliotis
   • Eugenia Halkia

   Gastrointestinal Oncology 21 June 2011 Pages: 200 - 201

10. Peritoneal Carcinomatosis from Gastric Cancer: Current Considerations for Systematic Management and Future Tendencies for Identification of Valid Predictors

    • Zhe Sun
    • Hui-Mian Xu

    Gastrointestinal Oncology 23 June 2011 Pages: 202 - 205

11. Evidence Expands Total Gastrectomy Decision for Asymptomatic Patients with CDH1 Inherited Mutations

    • T. Liakakos

    Gastrointestinal Oncology 17 June 2011 Pages: 206 - 207

12. Total Gastrectomy and Identified CDH1 Mutations: In Response

    • Jeffrey A. Norton
    • Yijun Chen

    Gastrointestinal Oncology 13 July 2011 Pages: 208 - 208

13. The Impact of Calculation Procedure on the Hazard Ratio of N Classifications

    • Cunjun Yu
    • Zhu Ying
    • Wenping Chen

    Gastrointestinal Oncology 03 June 2011 Pages: 209 - 210

14. Gastrectomy for Patients with Positive Peritoneal Cytology: Comments on the Article “Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients”

    • Hiroshi Okabe
    • Yoshiharu Sakai

    Gastrointestinal Oncology 12 April 2011 Pages: 211 - 212

15. Positive Peritoneal Cytology in Gastric Cancer

    • James J. Mezhir
    • Manish A. Shah
    • Vivian E. Strong

    Gastrointestinal Oncology 13 April 2011 Pages: 213 - 214

16. Common Deficiencies in Clinical Researches of N Classifications for Gastric Cancer

    • Cunjun Yu
    • Wenting He
    • Ping Liu

    Gastrointestinal Oncology 23 March 2011 Pages: 215 - 215

17. Relationship Between the Prognostic Accuracy of Metastatic Lymph Node Ratio and the Number of Retrieved Nodes

    • C. J. Yu
    • W. T. He
    • P. Liu

    Gastrointestinal Oncology 05 January 2011 Pages: 216 - 217

18. The American Society of Peritoneal Surface Malignancies (ASPSM)

    • Jesus Esquivel
    • Alexander Stojadinovic
    • Edward A. Levine

    Gastrointestinal Oncology 11 November 2010 Pages: 218 - 219

19. Surgical Management and Emerging Therapies to Prolong Survival in Metastatic Neuroendocrine Cancer

    • Skye C. Mayo
    • Mechteld C. de Jong
    • Timothy M. Pawlik

    Gastrointestinal Oncology 17 September 2010 Pages: 220 - 221

20. Surgical Management and Emerging Therapies to Prolong Survival in Metastatic Neuroendocrine Cancer

    • Akshat Saxena
    • Terence C. Chua
    • David L. Morris

    Gastrointestinal Oncology 24 September 2010 Pages: 222 - 223

21. The Importance of Preoperative Staging with Chest CT Scan in Patients with Colorectal Cancer

    • Raghava S. Pavoor
    • Parul J. Shukla
    • Jeffrey W. Milsom

    Colorectal Cancer 14 September 2010 Pages: 224 - 225

22. In Reply: The Importance of Preoperative Staging with Chest CT Scan in Patients with Colorectal Cancer

    • Irene Grossmann
    • Johannes Avenarius
    • Joost Klaase

    Colorectal Cancer 28 August 2010 Pages: 226 - 227

23. Ex Vivo Sentinel Lymph Nodes in Pathological Staging of Node-Negative Colorectal Carcinoma

    • Nadia Peparini
    • Piero Chirletti

    Colorectal Cancer 11 November 2010 Pages: 228 - 228

24. Reply to “Ex Vivo Sentinel Lymph Nodes in Pathological Staging of Node-Negative Colorectal Carcinoma,” by Peparini and Chirletti

    • Bruno Märkl
    • Therese Gannon Kerwel

    Colorectal Cancer 02 November 2010 Pages: 229 - 229

25. A Tale of Two Provinces: Regionalization of Pancreatic Surgery in Ontario and Quebec

    • Marko Simunovic
    • Nancy Baxter

    Colorectal Cancer 20 January 2011 Pages: 230 - 230

26. Preanalytical Interferences Compromise the Clinical Validity of Matrix Metalloproteinase 1 as Marker of Colorectal Cancer

    • Klaus Jung

    Colorectal Cancer 24 December 2010 Pages: 231 - 232

    

27. Reply: Preanalytical Interferences Compromise the Clinical Validity of Matrix Metalloproteinase 1 as Marker of Colorectal Cancer

    • Masaaki Iwatsuki
    • Koshi Mimori
    • Masaki Mori

    Colorectal Cancer 23 December 2010 Pages: 233 - 234

28. Prognostic Impact of Inferior Mesenteric Artery Lymph Node Metastasis in Colorectal Cancer

    • Panagiotis Taflampas
    • Manousos Christodoulakis
    • Eelco DeBree

    Colorectal Cancer 07 January 2011 Pages: 235 - 235

29. Reply about “Prognostic Impact of Inferior Mesenteric Artery Lymph Node Metastasis in Colorectal Cancer”

    • Jeonghyun Kang
    • Kang Young Lee

    Colorectal Cancer 12 January 2011 Pages: 236 - 236

30. Combined Resection of the Iliac Vessels for Lateral Pelvic Lymph Node Dissection can be Safely Performed Through Laparoscopic Approach

    • Tsuyoshi Konishi
    • Hiroya Kuroyanagi
    • Toshiaki Watanabe

    Colorectal Cancer 22 April 2011 Pages: 237 - 237

31. Technical Feasibility of Laparoscopic Lateral Pelvic Lymph Node Dissection for Patients with Low Rectal Cancer after Concurrent Chemoradiation Therapy: In Response

    • Jin-Tung Liang

    Colorectal Cancer 22 April 2011 Pages: 238 - 238

32. Dual Role of Autophagy in Colon Cancer Cell Survival

    • Shi Yu Yang
    • Marc C. Winslet

    Colorectal Cancer 21 May 2011 Pages: 239 - 239

33. High Ligation of Inferior Mesenteric Artery: A Standard Procedure for Colorectal Cancer?

    • Theodore Liakakos

    Colorectal Cancer 02 July 2011 Pages: 240 - 241

34. Reply to “High Ligation of Inferior Mesenteric Artery: A Standard Procedure for Colorectal Cancer?”

    • Jeonghyun Kang
    • Kang Young Lee

    Colorectal Cancer 12 July 2011 Pages: 242 - 243

35. Distal Pancreatectomy Combined with Celiac Axis Resection in Treatment of Carcinoma of the Body/Tail of the Pancreas: Proceed with Caution

    • Sun Hu Yang
    • Ke Feng Dou

    Pancreatic Tumors 22 October 2010 Pages: 244 - 244

36. Distal Pancreatectomy Combined with Celiac Axis Resection: An Alternative Approach for Some Advanced Diatal Pancreatic Cancer

    • Xubo Wu
    • Ran Tao
    • Peng Chongpeng

    Pancreatic Tumors 17 October 2010 Pages: 245 - 245

37. Erlotinib and Pancreatic Adenocarcinoma: Uncertainty and Hope

    • Odysseas Zoras
    • Charalambos Batsis

    Pancreatic Tumors 01 June 2011 Pages: 246 - 247

38. Does Pleomorphic Adenoma Really Require Total Parotidectomy?

    • Poramate Pitak-Arnnop
    • Kittipong Dhanuthai
    • Niels Christian Pausch

    Head and Neck Oncology 14 December 2010 Pages: 248 - 249

39. Central Compartment Reoperation for Recurrent/Persistent Differentiated Thyroid Cancer

    • Ritesh Agrawal
    • Anjali Mishra
    • Saroj Kanta Mishra

    Head and Neck Oncology 19 May 2011 Pages: 250 - 250

40. Endoscopic vs Robotic Thyroidectomy: Which is Better?

    • Brian Hung-Hin Lang
    • Man Po Chow
    • Kai Pun Wong

    Head and Neck Oncology Open access 10 June 2011 Pages: 251 - 251

41. New Approaches in Thyroid Surgery: Is There an Increased Risk of Nerve Injury?

    • Gianlorenzo Dionigi
    • Manuel Duran-Poveda

    Head and Neck Oncology 30 June 2011 Pages: 252 - 253

42. Should Indications for Skin-Reducing Mastectomy be Expanded?

    • Livio Colizzi
    • Tommaso Agostini
    • Davide Lazzeri

    Breast Oncology 26 August 2010 Pages: 254 - 255

43. Authors Reply to “Should Indications for Skin-Reducing Mastectomy be Expanded?”

    • Amit Nair
    • Pilar Matey

    Reconstructive Oncology 28 August 2010 Pages: 256 - 256

44. Comments on: Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery (Clough KB, Kaufman GJ, et al. ASO DOI 10.1245/s10434-009-0792-y)

    • F. Santanelli
    • G. Paolini
    • B. Longo

    Breast Oncology 03 September 2010 Pages: 257 - 258

45. Reply to Comments on: Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery

    • Krishna Clough
    • Gabriel Kaufman
    • Isabelle Sarfati

    Breast Oncology 16 September 2010 Pages: 259 - 260

46. Anti-cytokeratin CAM5.2 (BD Biosciences) and CK8 Give No Remarkable Advantages to the Pancytokeratin Cocktail of Antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in Detecting Disseminated Tumor Cells in Biologic Subtypes of Stage I–III Breast Cancer Patients

    • Wea-Lung Lin
    • Fong-Lin Chen
    • Chih-Ping Han

    Breast Oncology 02 December 2010 Pages: 261 - 262

47. Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 Give No Remarkable Advantages to the Pancytokeratin Cocktail of Antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in Detecting Disseminated Tumor Cells in Biologic Subtypes of Stage I–III Breast Cancer Patients

    • Savitri Krishnamurthy
    • Anthony Lucci

    Breast Oncology 06 November 2010 Pages: 263 - 264

48. Comparing Prediction Models: The Distinction Between Clinical and Statistical Significance

    • Anees B. Chagpar
    • Kelly M. McMasters

    Breast Oncology 23 November 2010 Pages: 265 - 265

49. Expanding the Indications for Latissimus Dorsi Musculocutaneous Flap in Totally Autologous Breast Reconstruction: The Extended Variant

    • Mario Dini
    • Fabio Quercioli
    • Tommaso Agostini

    Breast Oncology 21 December 2010 Pages: 266 - 270

50. Reply to “Letter to the Editor: Expanding the Indications for Latissimus Dorsi Musculocutaneous Flap in Totally Autologous Breast Reconstruction”

    • Gedge D. Rosson

    Reconstructive Oncology 07 December 2010 Pages: 271 - 271